Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/9671
DC FieldValueLanguage
dc.contributor.authorMinov, Jen_US
dc.contributor.authorStoleski, Sen_US
dc.contributor.authorPetrova, Ten_US
dc.contributor.authorVasilevska, Ken_US
dc.contributor.authorMijakoski, Den_US
dc.contributor.authorKaradzinska-Bislimovska, Jen_US
dc.date.accessioned2020-12-07T12:40:51Z-
dc.date.available2020-12-07T12:40:51Z-
dc.date.issued2020-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9671-
dc.language.isoen_USen_US
dc.publisherOpen Access Text Pvt, Ltd.en_US
dc.relation.ispartofHealth and Primary Careen_US
dc.subjectbacterial exacerbationen_US
dc.subjectchronic obstructive pulmonary diseaseen_US
dc.subjectclinical success rateen_US
dc.subjectlevofloxacinen_US
dc.subjectrelapsen_US
dc.subjectside effectsen_US
dc.titleEfficacy and safety of levofloxacin in the outpatient treatment of exacerbation of chronic obstructive pulmonary disease: levofloxacin 750 mg vs. levofloxacin 500 mgen_US
dc.typeArticleen_US
dc.identifier.doi10.15761/hpc.1000184-
dc.identifier.volume4-
dc.identifier.issue1-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

132
checked on 19.5.2025

Download(s)

126
checked on 19.5.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.